In today’s recent session, 14.16 million shares of the Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) have been traded, and its beta is -0.15. Most recently the company’s share price was $1.85, and it changed around $0.54 or 41.22% from the last close, which brings the market valuation of the company to $4.16M. LIXT at last check was trading at a discount to its 52-week high of $4.42, offering almost -138.92% off that amount. The share price’s 52-week low was $1.31, which indicates that the recent value has risen by an impressive 29.19% since then. We note from Lixte Biotechnology Holdings Inc’s average daily trading volume that its 10-day average is 72400.0 shares, with the 3-month average coming to 63.19K.

Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) trade information

Instantly LIXT has been showing a green trend so far today with a performance of 41.22% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.1600 on recent trading dayincreased the stock’s daily price by 14.35%. The company’s shares are currently down -21.28% year-to-date, but still down -7.50% over the last five days. On the other hand, Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) is -1.07% down in the 30-day period. We can see from the shorts that 18324.0 shares have been sold at a short interest cover period of 2.38 day(s).

Lixte Biotechnology Holdings Inc (NASDAQ:LIXT)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 20.48% of Lixte Biotechnology Holdings Inc shares, and 8.88% of them are in the hands of institutional investors. The stock currently has a share float of 11.17%.